About AMEND
We are here to break the isolation so often felt by those with these rare diseases, and we would be delighted to welcome you into our ‘family’.
The aim of our website is to direct you as quickly as possible to our support services and to information you can trust on multiple endocrine neoplasia (MEN) syndromes types 1, 2, and 3, medullary thyroid cancer (MTC), and Phaeochromocytoma and Paraganglioma (PPGL) syndromes.
- Who we are
- Aims of AMEND
- How we are governed
- Who our sponsors are
- Annual Reports & Accounts
- Coronavirus (COVID-19) Information
-
Make a donation
AMEND has a variety of ways to donate to show your appreciation for our work.
Donate now
-
Become an AMEND member
Membership is free so come and join our family.
Join us
-
Social Media
AMEND uses a number of social media channels to provide information and support.
Find out more
-
Latest News
There’s always something going on at AMEND. Check out the latest news
View News
-
Latest Video
Filmed main programme event sessions and other information.
Visit our Youtube channel
-
twitter feed
If you have been seen at the University of Cambridge in the UK in the past year for #pheo #para please take this sh… twitter.com/i/web/status/1… Retweeted by AMEND
Thank you @eje for the publication our comments related to the role of relative hypoxia on increased incidence of P… twitter.com/i/web/status/1… Retweeted by AMEND
Other featuring events of #MEDCspring2021 will be #Endocrine update on #Pheochromocytoma by Prof John Newell Pric… twitter.com/i/web/status/1… Retweeted by AMEND
Deadline for applications to our £20k thyroid cancer research Award is 30 April. Details and apply at:… twitter.com/i/web/status/1… Retweeted by AMEND
#RamadanKareem to all who are celebrating! It's not obligatory to fast during this time if you have adrenal insuff… twitter.com/i/web/status/1… Retweeted by AMEND
UK #MEN #PPGL #MTC and #ACC researchers. We look forward to receiving applications to our grant fund by 31 August… twitter.com/i/web/status/1…
@BartsHospital Congratulations everyone!
Our endocrinology department has become the first service of its kind in the world to be awarded a full five stars… twitter.com/i/web/status/1… Retweeted by AMEND
Younger patients with pheochromocytoma have a much higher incidence of germline genetic mutations. Most patients, e… twitter.com/i/web/status/1… Retweeted by AMEND